P/E ratio for Sequent Scientific (SEQUENT.NS)
P/E ratio as of May 2024 (TTM): -20.4
According to Sequent Scientific's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -20.3771. At the end of 2022 the company had a P/E ratio of -114.
P/E ratio history for Sequent Scientific from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -114 | -250.56% |
| 2021 | 75.6 | 79.16% |
| 2020 | 42.2 | 71.81% |
| 2019 | 24.5 | 544.78% |
| 2018 | 3.81 | -94.52% |
| 2017 | 69.4 | -198.71% |
| 2016 | -70.3 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.